POSA107 Apixaban Versus Other Anticoagulants in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: A Comparison of All-Cause and Event-Related Costs in Real-Life Setting in France
Abstract
Authors
M Belhassen O Hanon PG Steg I Mahé M Née F Jacoud F Dalon FE Cotte S Gollety C Marant-Micallef E Van Ganse B Falissard N Danchin